Targeting refractory sarcomas and malignant peripheral nerve sheath tumors in a phase I/II study of sirolimus in combination with ganetespib (SARC023)

Authors

AeRang Kim, Children's National Medical Center
Brian A. Van Tine, Washington University School of Medicine in St. Louis
et al

Journal

Sarcoma

Publication Date

1-31-2020

Volume

2020

First Page

5784876

Document Type

Open Access Publication

DOI

10.1155/2020/5784876

Rights and Permissions

AeRang Kim, Yao Lu, Scott H. Okuno, et al., "Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)," Sarcoma, vol. 2020, Article ID 5784876, 8 pages, 2020. DOI: 10.1155/2020/5784876 Copyright © 2020 AeRang Kim et al. 'is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Kim, AeRang; Van Tine, Brian A.; and et al, "Targeting refractory sarcomas and malignant peripheral nerve sheath tumors in a phase I/II study of sirolimus in combination with ganetespib (SARC023)." Sarcoma. 2020, 5784876 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/11092